Rallybio Corporation Common Stock RLYB

$16.96 +2.23% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-06 View →
4 4 2026-07-10 View →
8-K 8-K 2026-06-01 View →
4 OWNERSHIP DOCUMENT 2026-05-20 View →
4 OWNERSHIP DOCUMENT 2026-05-15 View →
4 OWNERSHIP DOCUMENT 2026-05-13 View →
10-Q 10-Q 2026-05-13 View →
4 OWNERSHIP DOCUMENT 2026-05-06 View →
8-K 8-K 2026-05-04 View →
8-K 8-K 2026-03-31 View →
10-K 10-K 2026-03-16 View →
8-K 8-K 2026-03-02 View →
4 FORM 4 2026-02-23 View →
4 FORM 4 2026-02-20 View →
4 FORM 4 2026-02-20 View →
8-K 8-K 2026-01-29 View →
DEF 14A DEF 14A 2026-01-02 View →
10-Q 10-Q 2025-11-06 View →
8-K 8-K 2025-11-06 View →
8-K 8-K 2025-08-29 View →
10-Q 10-Q 2025-08-07 View →
8-K 8-K 2025-08-07 View →
8-K 8-K 2025-07-08 View →
8-K 8-K 2025-06-27 View →
8-K 8-K 2025-05-16 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
4 FORM 4 2025-05-15 View →
10-Q 10-Q 2025-05-08 View →
8-K 8-K 2025-05-08 View →
8-K 8-K 2025-04-08 View →
DEF 14A DEF 14A 2025-04-07 View →
8-K 8-K 2025-03-13 View →
424B5 424B5 2025-03-13 View →
10-K 10-K 2025-03-13 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$16.96
Market Cap
$88.10 million
52-Week Range
$2.88 – $17.57
Average Volume
37K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.